Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region y box 6 in hepatocellular carcinoma

Cancer

Volumn 118, Issue 9, 2012, Pages 2431-2442

  Xie, Qing ^a   Chen, Xiangmei ^a   Lu, Fengmin ^a   Zhang, Ting ^a   Hao, Meili ^a,b   Wang, Yongfeng ^a   Zhao, Jingmin ^c   McCrae, Malcolm A ^d   Zhuang, Hui ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c BEIJING 302 HOSPITAL   (China)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

hepatocellular carcinoma; microRNA; miR 155; p21waf1 cip1; p53

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; MICRORNA; MICRORNA 155; ONCOMIR; PROTEIN P53; SEX DETERMINING REGION Y BOX 6 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONSTRUCT; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE SOX6; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; GENE KNOCKDOWN TECHNIQUES; HEP G2 CELLS; HEPATITIS B VIRUS; HUMANS; LIVER; LIVER NEOPLASMS; MICE; MICE, NUDE; MICRORNAS; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS P21(RAS); SOXD TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84857981395     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26566     Document Type: Article

References (21)

1. El-Serag HB,. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2002; 35: S72-S78.
2. El-Serag HB,. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2001; 5: 87-107.
3. Wild CP, Gong YY,. Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis. 2010; 31: 71-82.
4. Hussain SP, Schwank J, Staib F, Wang XW, Harris CC,. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene. 2007; 26: 2166-2176.
5. Calin GA, Croce CM,. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006; 6: 857-866.
6. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T,. Identification of tissue-specific microRNAs from mouse. Curr Biol. 2002; 12: 735-739.
7. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006; 103: 2257-2261.
8. Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005; 65: 7065-7070.
9. Szafranska AE, Davison TS, John J, et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene. 2007; 26: 4442-4452.
10. Tili E, Michaille JJ, Wernicke D, et al. Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proc Natl Acad Sci U S A. 2011; 108: 4908-4913.
11. Wang B, Majumder S, Nuovo G, et al. Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology. 2009; 50: 1152-1161.
12. Ohe K, Tamai KT, Parvinen M, Sassone-Corsi P,. DAX-1 and SOX6 molecular interplay results in an antagonistic effect in pre-mRNA splicing. Dev Dyn. 2009; 238: 1595-1604.
13. Haraguchi T, Ozaki Y, Iba H,. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells [serial online]. Nucleic Acids Res. 2009; 37: e43.
14. Cao ZA, Daniel D, Hanahan D,. Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer [serial online]. BMC Cancer. 2002; 2: 11.
15. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189: 12-19.
16. Taganov KD, Boldin MP, Chang KJ, Baltimore D,. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006; 103: 12481-12486.
17. Eis PS, Tam W, Sun L, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A. 2005; 102: 3627-3632.
18. Yoon SO, Chun SM, Han EH, et al. Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma [published online ahead of print March 31, 2011]. Hum Pathol. 2011.
19. Faraoni I, Antonetti FR, Cardone J, Bonmassar E,. miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta. 2009; 1792: 497-505.
20. Iguchi H, Urashima Y, Inagaki Y, et al. SOX6 suppresses cyclin D1 promoter activity by interacting with beta-catenin and histone deacetylase 1, and its down-regulation induces pancreatic beta-cell proliferation. J Biol Chem. 2007; 282: 19052-19061.
21. Korinek V, Barker N, Willert K, et al. Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse. Mol Cell Biol. 1998; 18: 1248-1256.